Vancomycin
Vancomycin antibiotic medicaments for therapeutic use
HSN 3004 20 96 (Vancomycin) is subject to Central Drugs Standard Control Organisation (CDSCO) drug registration and import licensing under the Drugs and Cosmetics Act, 1940, with mandatory pre-import documentation uploaded in e-Sanchit before out-of-charge. The Directorate General of Foreign Trade (DGFT) classifies this tariff line under pharmaceutical import policy controls, and an oxytocin-prohibition overlay under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022 applies to co-classified substances in the heading.
- Registration certificate from CDSCO
- Import licence from CDSCO
- Batch release certificate from CDSCO
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Obtain a valid drug registration certificate and import licence for Vancomycin from the Central Drugs Standard Control Organisation before the consignment departs the origin country. Both the registration certificate (document code 101dc1) and the import licence for drugs (document code 9111dc) must be uploaded in e-Sanchit at the bill of entry before customs out-of-charge.Drugs and Cosmetics Act, 1940 · document codes 101dc1 and 9111dc
- 2Upload the Certificate of Analysis for the drug (document code 0010dc), the Batch Release Certificate (document code 0030dc), and the Label of the Consignment (document code 0110dc) in e-Sanchit. The proper officer will verify all five mandatory documents before granting out-of-charge on PGA-facilitated bills.CBIC e-Sanchit mandatory document verification requirement · document codes 0010dc, 0030dc, 0110dc
The most common error on this tariff line is filing the bill of entry with the registration certificate but without a current, product-specific import licence — the two are distinct instruments and both are mandatory at out-of-charge. Vancomycin is an antibiotic in a heading that also covers oxytocin, which is prohibited for import under S.O. 2357(E); a misdescribed or broadly-worded invoice referencing the heading rather than the specific molecule can trigger the oxytocin-prohibition scrutiny and consignment detention pending CDSCO clarification.